Top Markets
Coin of the day
Xspray Pharma AB (publ) Xspray Pharma AB (publ)

Xspray Pharma AB (publ)

XSPRAY
Pozycja w akcjach #24988
Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden,... Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden, specializes in developing protein kinase inhibitors for precise cancer treatments. Their current drug pipeline includes HyNap-Nilo, aimed at chronic myeloid leukemia; HyNap-Sora, which targets renal, liver, and several types of thyroid cancer; and HyNap-Dasa, intended for both chronic myeloid leukemia and acute lymphoblastic leukemia. Established in 2003, the company was formerly known as Xspray Microparticles AB until its name change to Xspray Pharma AB (publ) in 2017.
Cena akcji
$1.19
Kapitalizacja rynkowa
$56.35M
Zmiana (1 dzień)
2.31%
Zmiana (1 rok)
-73.10%
Kraj
SE
Handel Xspray Pharma AB (publ) (XSPRAY)

Kategoria

Historia ceny akcji dla Xspray Pharma AB (publ) (XSPRAY)
Najwyższa cena zamknięcia: $1.45 dnia 2026-08-01

Najniższa cena zamknięcia: $3.96 dnia 2017-09-01
Historia cen akcji firmy Xspray Pharma AB (publ) od 2017 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -10.08%
2025 -16.04%
2024 6.84%
2023 -29.58%
2022 -28.28%
2021 -59.39%
2020 114.77%
2019 11.88%
2018 36.91%
2017 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.70 -18.24%
AU
$760.57 8.46%
CH
$130.43 397.46%
US